Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)

CompletedOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2014

Conditions
Coronary Artery Disease
Interventions
DEVICE

Xience

Patients with Xience

Trial Locations (1)

138-739

Asan medical center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

collaborator

Abbott

INDUSTRY

lead

Seung-Jung Park

OTHER